Skip to content

A clinical study to see effect of two different inhalation agents (Sevoflurane vs Desflurane) on blood oxygen levels during ventilation of single lung in cancer patients.

A comparison of effect of Desflurane vs Sevoflurane on arterial oxygenation during one lung ventilation for thoracotomies in oncosurgical patients: - A Randomized Control Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027384
Enrollment
66
Registered
2020-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified Health Condition 2: C399- Malignant neoplasm of lower respiratory tract, part unspecified Health Condition 3: C383- Malignant neoplasm of mediastinum,part unspecified Health Condition 4: C768- Malignant neoplasm of other specified ill-defined sites Health Condition 5: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung Health Condition 6: C390- Malignant neoplasm of upper respiratory tract, part unspecified

Interventions

Intervention1: Desflurane: Patient will be maintained on Desflurane based anaesthesia during the period of One lung ventilation while maintaining the BIS score in the range of 40-60. Fraction of oxyge

Sponsors

Dr BRAIRCH AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age of 18 years or older, but less than 70 years. 2.ASA Status I to III. 3.Patients undergoing surgeries requiring One Lung Ventilation. 4.Agree to participate in the study and have signed written informed consent.

Exclusion criteria

Exclusion criteria: 1.Symptomatic or Severe Obstructive or Restrictive Lung disease. Accepted definition for obstructive disease as defined by the American Thoracic Society and European Respiratory Society Guidelines is FEV1/FVC 2.Requirement of preoperative oxygen support. 3.Preoperative intubation state or under mechanical ventilator support. 4.Baseline arterial pressure of oxygen (Pao2) 5.Symptomatic coronary or peripheral arterial disease 6.Allergic to any drug used during the study. 7.Patients preoperatively on drugs that directly affect Hypoxic pulmonary vasoconstriction (HPV).

Design outcomes

Primary

MeasureTime frame
Arterial OxygenationTimepoint: 1.on Room air 2.15 minutes after positioning in lateral decubitus on two lung ventilation. 3. every 15 minutes for next 60 monutes on one lung ventilation ventilation

Secondary

MeasureTime frame
Late effects on cardiac and pulmonary functions between the two agents using CPET and PFTTimepoint: 1.preoperative 2.postoperative 6 week 3.postoperative 12 week ;To compare perioperative complicationsTimepoint: 1.intraoperatively 2.on postoperative day 0 and 1;To evaluate effect on coagulation parametersTimepoint: 1. preoperatively 2. 15 minutes after positioning patient in lateral decubitus position on two lung ventilation 3.termination of OLV;To evaluate Recovery after anaesthesiaTimepoint: on postoperative day 0 and 1

Countries

India

Contacts

Public ContactDr Sachidanand Jee Bharati

Dr. BRAIRCH AIIMS, New Delhi

sachidadr@yahoo.co.in9968436042

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026